Strategic Partnerships Polarean has active collaboration and supply agreements with major medical centers (University of Virginia Health, SimonMed, KU Medical Center). This indicates a sales opportunity to expand partnerships with large healthcare networks and imaging centers that already demonstrate adoption of Xenon MRI technology.

Clinical Adoption FDA-approved Xenon MRI agent XENOVIEW and integration into clinical workflows position Polarean as a solution for pulmonary diagnostics. Target hospitals and clinics expanding lung imaging capabilities and noninvasive functional imaging to drive procurement conversations.

Expansion Momentum Recent financing and pilot deployments suggest momentum for scaling. Opportunities exist to upsell additional system components, software, and service contracts as the installed base grows across academic and community hospitals.

Key Influencers Appointment of a Chief Medical Advisor and active participation in major pulmonary conferences indicate access points with clinical leaders. Leverage these relationships to accelerate ROI-focused discussions with decision-makers in radiology and pulmonology.

Global Reach With offices in the US and UK and a growing international installed base, there is potential to target cross-border deployments, distributor partnerships, and regional regulatory support to broaden market coverage and reduce time-to-sale.